FMS - DaVita Fresenius said to be under FTC antitrust probe
2024-07-13 08:53:34 ET
More on DaVita, Fresenius, etc.
- Fresenius Medical Care: Significant Upside Remains
- DaVita: A Stellar Run With EPS Upside Likely Ahead, Downgrading On Valuation
- Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript
- U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact
- Fresenius down 6% despite bottom-line beat